Search

AngioDynamics Inc

Fechado

SetorSaúde

15.2 0.26

Visão Geral

Variação de preço das ações

24h

Atual

Mín

14.76

Máximo

15.37

Indicadores-chave

By Trading Economics

Rendimento

-3.3M

-11M

Vendas

8.2M

87M

EPS

-0.07

Margem de lucro

-13.169

Funcionários

632

EBITDA

-26M

-28M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+38.43% upside

Dividendos

By Acuity

Próximos Ganhos

1 de out. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

36M

565M

Abertura anterior

14.94

Fecho anterior

15.2

Sentimento de Notícias

By Acuity

84%

16%

314 / 340 Ranking em Healthcare

AngioDynamics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de ago. de 2026, 20:02 UTC

AngioDynamics Inc shares are higher today, supported by gains in the Health Care Equipment sector. The stock remains above its 20-day moving average.

31 de jul. de 2026, 19:33 UTC

AngioDynamics shares are lower amid broader market dynamics and rising bond yields, despite remaining above the 20-day moving average.

30 de jul. de 2026, 18:56 UTC

AngioDynamics Inc. shares are trading roughly flat, remaining above their 20-day moving average after four consecutive sessions of higher closes.

29 de jul. de 2026, 19:56 UTC

Macro Event

AngioDynamics Inc shares are higher since Tuesday, reflecting volatility from the Federal Reserve's interest rate decision and easing inflation data.

28 de jul. de 2026, 20:02 UTC

News

AngioDynamics will participate in two investor conferences this week, contributing to a notable increase in shares during Tuesday's session.

27 de jul. de 2026, 19:56 UTC

AngioDynamics Inc is rising amid strength in the health care equipment sector. The stock reached a peak earlier in the session before moderating gains.

24 de jul. de 2026, 18:36 UTC

AngioDynamics Inc is trading higher today, reflecting a positive market response. The stock remains above its 20-day moving average amid no specific news.

23 de jul. de 2026, 20:03 UTC

AngioDynamics Inc. shares are lower today, reflecting a decline from Wednesday's close amid broader market weakness in tech stocks related to rising AI capital expenditures.

22 de jul. de 2026, 19:56 UTC

AngioDynamics Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

21 de jul. de 2026, 20:06 UTC

News

AngioDynamics Inc shares are higher today, supported by a strong Nasdaq 100 Index. Analysts maintain a Hold rating amid optimism for NanoKnife technology.

20 de jul. de 2026, 19:46 UTC

News

AngioDynamics shares are higher today, despite a downgrade to "strong sell" from Zacks Research and a price target increase from Canaccord Genuity to $20.00.

Comparação entre Pares

Variação de preço

AngioDynamics Inc Previsão

Preço-alvo

By TipRanks

38.43% parte superior

Previsão para 12 meses

Média 21 USD  38.43%

Máximo 24 USD

Mínimo 19 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para AngioDynamics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

3 ratings

3

Comprar

0

Manter

0

Vender

Sentimento

By Acuity

314 / 340 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.
help-icon Live chat